AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

NIFUROXAZIDE 200.000 Mg ;

10 registrations across 1 African market— 10 active

Markets with NIFUROXAZIDE 200.000 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
DROTAVEX
Hard Gelatin Capsules
🇪🇬EgyptEva pharma for Pharmaceuticals and Medical Appliances - Eva Pharmaactive
ANTINAL
Hard Gelatin Capsules
🇪🇬EgyptAmoun Pharmaceutical Companyactive
Diaxnol
Hard Gelatin Capsules
🇪🇬EgyptEl OBOUR MODERN PHARMACEUTICAL INDUSTRIES-EGYPTactive
NITROFURINAL 200mg
Hard Gelatin Capsules
🇪🇬Egyptpharaonia pharmaceuticals (pharo pharma)active
DIAX
Hard Gelatin Capsules
🇪🇬EgyptHikma pharmaactive
DROTAVEX
Hard Gelatin Capsules
🇪🇬EgyptEva pharma for Pharmaceuticals and Medical Appliances - Eva Pharmaactive
NITROFURINAL 200mg
Hard Gelatin Capsules
🇪🇬Egyptpharaonia pharmaceuticals (pharo pharma)active
ANTINAL
Hard Gelatin Capsules
🇪🇬EgyptAmoun Pharmaceutical Companyactive
DIAX
Hard Gelatin Capsules
🇪🇬EgyptHikma pharmaactive
Diaxnol
Hard Gelatin Capsules
🇪🇬EgyptEl OBOUR MODERN PHARMACEUTICAL INDUSTRIES-EGYPTactive

NIFUROXAZIDE 200.000 Mg ; in Africa — Regulatory Overview

NIFUROXAZIDE 200.000 Mg ; is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.